✦ LIBER ✦

A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients

✍ Scribed by Isabelle Bedrosian; Gildy V. Babiera; Elizabeth A. Mittendorf; Henry M. Kuerer; Laura Pantoja; Kelly K. Hunt; Savitri Krishnamurthy; Funda Meric-Bernstam

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 148 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25096

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of the first phase 1 clinical tr

Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients : United States Military Cancer Institute Clinical Trials Group Study I-04

✍ Mark G. Carmichael; Linda C. Benavides; Jarrod P. Holmes; Jeremy D. Gates; Eliza 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views